本义 发表于 2025-3-21 19:21:07

书目名称Urologic Oncology影响因子(影响力)<br>        http://impactfactor.cn/if/?ISSN=BK0944306<br><br>        <br><br>书目名称Urologic Oncology影响因子(影响力)学科排名<br>        http://impactfactor.cn/ifr/?ISSN=BK0944306<br><br>        <br><br>书目名称Urologic Oncology网络公开度<br>        http://impactfactor.cn/at/?ISSN=BK0944306<br><br>        <br><br>书目名称Urologic Oncology网络公开度学科排名<br>        http://impactfactor.cn/atr/?ISSN=BK0944306<br><br>        <br><br>书目名称Urologic Oncology被引频次<br>        http://impactfactor.cn/tc/?ISSN=BK0944306<br><br>        <br><br>书目名称Urologic Oncology被引频次学科排名<br>        http://impactfactor.cn/tcr/?ISSN=BK0944306<br><br>        <br><br>书目名称Urologic Oncology年度引用<br>        http://impactfactor.cn/ii/?ISSN=BK0944306<br><br>        <br><br>书目名称Urologic Oncology年度引用学科排名<br>        http://impactfactor.cn/iir/?ISSN=BK0944306<br><br>        <br><br>书目名称Urologic Oncology读者反馈<br>        http://impactfactor.cn/5y/?ISSN=BK0944306<br><br>        <br><br>书目名称Urologic Oncology读者反馈学科排名<br>        http://impactfactor.cn/5yr/?ISSN=BK0944306<br><br>        <br><br>

正式演说 发表于 2025-3-21 20:36:22

http://reply.papertrans.cn/95/9444/944306/944306_2.png

开始发作 发表于 2025-3-22 03:48:04

Tobias Grimm,Jan-Friedrich Jokisch,Alexander Karl cryogenic engineering and applications. All of the papers published must (1) be presented at the conference, (2) pass the peer review process, and (3) report p978-1-4757-9049-8978-1-4757-9047-4Series ISSN 0065-2482

faculty 发表于 2025-3-22 07:39:23

Anja Lorch,Günter Niegisch and his Jazz Big Band at the conference banquet. This 1999 ICMC Conference was chaired by Julian Cave of IREQ - Institut de recherche d‘Hydro-Quebec, and the P978-0-306-46398-3978-1-4615-4293-3Series ISSN 0065-2482

检查 发表于 2025-3-22 10:24:34

http://reply.papertrans.cn/95/9444/944306/944306_5.png

和平 发表于 2025-3-22 13:15:15

Symptoms, Diagnosis, and Staging in Testicular Cancer,only recommended in the follow-up of patients with a seminoma postchemotherapy and a residual mass larger than 3 cm and should not be performed before 8 weeks after chemotherapy. Histogenetically, testicular tumors are divided into malignant germ cell tumors, stromal tumors, mixed germ cell stromal

Receive 发表于 2025-3-22 19:15:13

http://reply.papertrans.cn/95/9444/944306/944306_7.png

漂泊 发表于 2025-3-23 01:10:38

Management of Clinical Stage I (CSI) Disease in Testicular Cancer, about carboplatinum report about a 9–10% relapse rate in the long term. Therefore actually it is discussed to recommend surveillance for all clinical stage I seminoma patients..Risk-adapted treatment in clinical stage I nonseminoma offered one course of PEB chemotherapy to high-risk patients with 3

过时 发表于 2025-3-23 02:35:05

http://reply.papertrans.cn/95/9444/944306/944306_9.png

没血色 发表于 2025-3-23 06:03:08

Epidemiology and Sociocultural Differences for Bladder Cancer, mainly due population aging, BCa will become even more frequent, resulting in an even bigger public health challenge. Indeed, BCa is the most cost-intensive cancer per person mainly because of the excessive costs related to the high recurrence rate and ongoing invasive monitoring required in the su
页: [1] 2 3 4 5 6 7
查看完整版本: Titlebook: Urologic Oncology; Axel Merseburger,Maximilian Burger Living reference work 20200th edition Bladder Cancer.Diagnosis.Oncology.Prostate Ca